Literature DB >> 6487728

On the use of case series to identify disease risk factors.

R L Prentice, W M Vollmer, J D Kalbfleisch.   

Abstract

Methods to identify disease risk factors from a series of cases are considered. These include methods that compare risk factor levels among diagnostic categories and methods that relate risk factor levels to age at diagnosis, with a single diagnostic category. Statistical aspects considered include modelling assumptions, parameter identifiability, hypothesis-testing efficiency, assumptions concerning unsampled diagnostic categories and requirements for risk factor data and confounding factor data. It is argued that methods to identify risk factors using data on a single diagnostic category involve such strong assumptions that they have limited usefulness. Analyses that compare risk factor levels among diagnostic categories, on the other hand, should continue to play an important role in epidemiologic research, though there are important limitations in relation to analyses involving disease-free controls.

Keywords:  Data Analysis; Diseases; Epidemiologic Methods; Models, Theoretical; Research Methodology

Mesh:

Substances:

Year:  1984        PMID: 6487728

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  6 in total

Review 1.  What can we learn about disease etiology from case-case analyses? Lessons from breast cancer.

Authors:  María Elena Martínez; Giovanna I Cruz; Abenaa M Brewster; Melissa L Bondy; Patricia A Thompson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-09-24       Impact factor: 4.254

2.  The case-only independence assumption: associations between genetic polymorphisms and smoking among controls in two population-based studies.

Authors:  M Elizabeth Hodgson; Andrew F Olshan; Kari E North; Charles L Poole; Donglin Zeng; Chiu-Kit Tse; Tope O Keku; Joseph Galanko; Robert Sandler; Robert C Millikan
Journal:  Int J Mol Epidemiol Genet       Date:  2012-11-15

Review 3.  Smoking and selected DNA repair gene polymorphisms in controls: systematic review and meta-analysis.

Authors:  M Elizabeth Hodgson; Charles Poole; Andrew F Olshan; Kari E North; Donglin Zeng; Robert C Millikan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-10-08       Impact factor: 4.254

4.  E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium.

Authors:  Hisani N Horne; Hannah Oh; Mark E Sherman; Maya Palakal; Stephen M Hewitt; Marjanka K Schmidt; Roger L Milne; David Hardisson; Javier Benitez; Carl Blomqvist; Manjeet K Bolla; Hermann Brenner; Jenny Chang-Claude; Renata Cora; Fergus J Couch; Katarina Cuk; Peter Devilee; Douglas F Easton; Diana M Eccles; Ursula Eilber; Jaana M Hartikainen; Päivi Heikkilä; Bernd Holleczek; Maartje J Hooning; Michael Jones; Renske Keeman; Arto Mannermaa; John W M Martens; Taru A Muranen; Heli Nevanlinna; Janet E Olson; Nick Orr; Jose I A Perez; Paul D P Pharoah; Kathryn J Ruddy; Kai-Uwe Saum; Minouk J Schoemaker; Caroline Seynaeve; Reijo Sironen; Vincent T H B M Smit; Anthony J Swerdlow; Maria Tengström; Abigail S Thomas; A Mieke Timmermans; Rob A E M Tollenaar; Melissa A Troester; Christi J van Asperen; Carolien H M van Deurzen; Flora F Van Leeuwen; Laura J Van't Veer; Montserrat García-Closas; Jonine D Figueroa
Journal:  Sci Rep       Date:  2018-04-26       Impact factor: 4.379

5.  Cancer diagnostic profile in children with structural birth defects: An assessment in 15,000 childhood cancer cases.

Authors:  Jeremy M Schraw; Tania A Desrosiers; Wendy N Nembhard; Peter H Langlois; Robert E Meyer; Mark A Canfield; Sonja A Rasmussen; Tiffany M Chambers; Logan G Spector; Sharon E Plon; Philip J Lupo
Journal:  Cancer       Date:  2020-05-29       Impact factor: 6.860

6.  Analysis of Observational Self-matched Data to Examine Acute Triggers of Outcome Events with Abrupt Onset.

Authors:  Elizabeth Mostofsky; Brent A Coull; Murray A Mittleman
Journal:  Epidemiology       Date:  2018-11       Impact factor: 4.822

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.